About this trial
Objectives:
The primary aim of this project is to establish the effectiveness of an individualised stepped, multidisciplinary intervention, including education and peer support group, delivered via a virtual multimodal (p)rehabilitation hub, in reducing postoperative complications within 30-days following colorectal cancer surgery, compared to usual care alone.
The secondary aims will be to obtain data on the likely difference in key outcomes including:
(i) Quality of life (EORTC QLQ-C30 and QLQ-CR29) (ii) Number of days at home within 30, 90 and 365 days after surgery (DAH-30, 90, 365) (iii) Quality of recovery (QoR-15) (iv) Cost-effectiveness (v) Implementation metrics (RE-AIM)
Our hypothesis is that the PRIORITY-CONNECT 2 intervention will be more effective in reducing postoperative complications and more cost-effective than usual care.
Study design:
Pragmatic Randomised Type I Hybrid Effectiveness-Implementation Trial.
Planned sample size:
To achieve the primary aim, 564 participants will provide 90% power to detect a 15% difference in 30-day postoperative complication rates between the intervention and control groups. The sample size calculation accounts for up to 10% loss to follow-up, 5% non-compliance and a two-side alpha of 0.05.
Selection criteria:
A sample of 564 participants undergoing colorectal cancer surgery including open, laparoscopic or robotic-assisted surgery (mostly, anterior resection, sigmoid colectomy, hemicolectomy, total proctocolectomy, subtotal colectomy, total colectomy) at sites throughout Australia will be included. These are common colorectal cancer surgeries performed at the participating centres. All the surgeons involved in this study have clinical appointments in their respective hospitals.
Inclusion: Adults aged ≥18 years undergoing elective major surgery for colon or rectal cancer with curative intent; and consulting a colorectal surgeon at least 1 week prior to scheduled surgery.
Exclusion: Patients undergoing Pelvic Exenteration (PE), Cytoreductive Surgery (CRS) with or without HIPEC, or concurrent surgery for metastatic disease; or cognitive impairment such that they are unable to provide informed consent.
Study Procedure:
Participant's treating team will screen and provide an information sheet about the trial to consecutive patients. Interested patients will be contacted by a study researcher to discuss the trial further, answer any questions, confirm eligibility against the inclusion and exclusion criteria, and consent patients. Consenting patients will undergo baseline assessment and be randomised to a virtual multimodal hub (Intervention group) or usual care alone (Control group). The intervention will include the delivery of usual care and evidence-based exercise, nutritional, psychological and nursing interventions, and / or group-delivered peer support. All interventions will be conducted before and after surgery.
Duration of the Study:
Approximately 60 months.
Funding:
Medical Research Future Fund (MRFF) 2023 Early and Mid-Career Researchers (Application ID: 2031563).
Sponsor:
The University of Sydney.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged ≥18 years undergoing elective major surgery for colon or rectal cancer with curative intent
Consulting with a colorectal cancer surgeon at least 1 week prior to scheduled surgery
Disqualifiers
Patients undergoing Pelvic Exenteration (PE), Cytoreductive Surgery (CRS) with or without HIPEC, or concurrent surgery for metastatic disease
Cognitive impairment such that they are unable to provide informed consent
Trial design
Parallel
Treatments tested in this trial
Preoperative Exercise
BehavioralAerobic, Endurance, Respiratory, Muscle Strength, Education
Postoperative Exercise
BehavioralAerobic, Endurance, Respiratory, Muscle Strength, Education
Preoperative Nutrition
Dietary supplementMalnutrition screening, Weight monitoring, Symptom management, Dietetic counselling, Nutrition support
Postoperative Nutrition
Dietary supplementMalnutrition screening, Weight monitoring, Symptom management, Dietetic counselling, Nutrition support
Preoperative Psychology
BehavioralCBT skills, Skills training, Emotional validation, Behavioural activation, Psycho-education
Postoperative Psychology
BehavioralCBT skills, Skills training, Emotional validation, Behavioural activation, Psycho-education
Preoperative Nursing
Other interventionRisk management, Managing pain, Wound care, Bowel function, Surgical education
Postoperative Nursing
Other interventionRisk management, Managing pain, Wound care, Bowel function/Stoma management, Education
Preoperative Peer Support Group
BehavioralFortnightly sessions moderated by a social worker including patients and carers: Safe space, Share experiences/ideas, Support, Education
Postoperative Peer Support Group
BehavioralFortnightly sessions moderated by a social worker including patients and carers: Safe space, Share experiences/ideas, Support, Education
Usual Care
Other interventionAll participants will receive usual care according to their health care team, which may consist of advice on smoking cessation, reduction of alcohol intake, nutritional counselling, and medical optimisation in the preoperative anaesthetic clinic visits.
Treatment groups
Trial outcomes
Primary outcomes
Proportion of participants developing postoperative complications within 30 days after surgery.
The primary outcome will be the proportion of participants developing postoperative complications within 30 days after surgery, defined as any deviation from the normal postoperative course and classified according to the Clavien-Dindo classification. The risk of developing complications following colorectal cancer surgery is highest in the first 30-days after surgery; this is a critical determinant of recovery, long-term outcomes, and colorectal cancer treatment costs.
Secondary outcomes
Quality of Life Outcome (EORTC QLQ-C30 and QLQ-CR29)
The European Organization for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ) are validated, cancer-specific tools commonly used to assess quality of life in colorectal cancer patients. The QLQ-C30 includes 30 items assessing five functional domains, nine symptom scales, financial impact and overall quality of life. The QLQ-CR29 is a 29-item tool to evaluate symptoms (gastrointestinal, urinary, pain and others) and functional areas (sexual, body image and others) that are associated with colorectal cancer and its treatments. Both tools use scales ranging from 0 to 100. Higher scores on functional and global health scales reflect better functioning or quality of life, whereas higher scores on symptom scales indicate greater symptom burden or problems.
Quality of Recovery (QoR-15)
The QoR-15 is a validated tool designed to assess the quality of recovery after surgery. It consists of 15 items rated on an 11-point numerical rating scale ranging from 0 to 10. The overall QoR-15 score is calculated by summing all individual item scores, resulting in a total score ranging from 0 to 150, where higher scores indicate a better quality of recovery. Recovery will be defined as return to baseline values or better in each of the questions or assessments.
Number of days at home within 30, 90 and 365 days of surgery (DAH-30, 90, 365)
Validated (Australian-population) patient-centred outcome metrics that integrates length of hospital stay, discharge destination (other than home), hospital readmission and early death. The number of days at home is reduced by, for example, complications elongating acute hospital bed stay, discharge to a care facility, re-admission, and death. This is quantified as the days alive and at home during the 30 days after surgery. Days at home is calculated using mortality and hospitalisation data from the date of the index surgery (= Day 0).
Resource use (costs)
Patient and health system resource use, including the cost of the virtual multimodal hub interventions, hospitalisations, will be collected (surveys) from randomisation (1-6 weeks prior to surgery) to 12 months post index surgery.
Other outcomes
Pain (NPRS)
The Numeric Pain Rating Scale (NPRS) is a widely used tool for assessing pain intensity in individuals. It is a segmented numeric scale where respondents select a whole number (0-10) that best reflects their pain intensity. The scale ranges from 0, indicating "no pain," to 10, representing "the worst pain imaginable." This method allows for a straightforward and quantifiable measure of pain, facilitating communication between patients and healthcare providers.
Exercise capacity (30sSTS)
30 seconds Sit-to-Stand Test (30sSTS) is a reliable and valid tool in evaluating functional exercise capacity in patients.The 30sSTS the performance of as many sit-to-stand actions as possible in 30 seconds without upper limb involvement.
Self-reported physical activity (IPAQ-SF)
International Physical Activity Questionnaire short form (IPAQ-SF) measures the types of intensity of physical activity and sitting time that people do as part of their daily lives. The questionnaire asks participants to report any physical activity (performed for at least 10 minutes) during the last seven days reported as hours per day, minutes per day, and days per week. This aims to be an estimate of total physical activity. IPAQ-SF has demonstrated high reliability and validity.
Nutritional Status (PG-SGA SF)
Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) includes four patient-generated historical components (Weight History, Food Intake, Symptoms and Activities and Function).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Surgical Outcomes Research Centre (SOuRCe)
Lead sponsor
University of Sydney
Collaborator
Medical Research Future Fund
Collaborator